Alliqua (ALQA) Offers Prelim. Q3 Results; Sees Revenue Growth of 16%

October 5, 2016 4:06 PM EDT
Get Alerts ALQA Hot Sheet
Trade ALQA Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Alliqua BioMedical, Inc. (Nasdaq: ALQA) announced preliminary third quarter of fiscal year 2016 revenue results and timing and details of the third quarter financial results conference call.

Third Quarter Preliminary Revenue Estimate:

While the Company has not finalized its full financial results for the nine month period ended September 30, 2016, it expects third quarter total revenue from continuing operations of approximately $4.85 million compared to $4.19 million last year, representing growth of approximately 16% year-over-year. The Company further estimates that sales of products were $4.35 million and that contract manufacturing sales were approximately $500,000 for the third quarter of 2016. Product revenue for the third quarter of 2016 represents growth of approximately 19% on both a year-over-year and on a quarter-over-quarter basis.

“We are extremely pleased with our third quarter revenue results, led by continued commercial progress within our biologics franchise and a record quarter for MIST Therapy,” said David Johnson, Chief Executive Officer of Alliqua BioMedical. “We look forward to sharing our full financial and operating results during our investor call on November 4th.”

The financial information presented above is a preliminary estimate only, has not been reviewed by the Company's independent registered accounting firm and is subject to change upon completion of the review of the Company’s financial statements as of and for the quarter ended September 30, 2016. Additional information and disclosures would be required for a more complete understanding of the Company’s financial position and results of operations as of September 30, 2016.

Third Quarter Fiscal 2016 Financial Results Conference Call:

Chief Executive Officer, David Johnson, and Chief Financial Officer, Brian Posner, will host a teleconference at 8:00 a.m. Eastern Time on November 4th to discuss the results of the quarter and to host a question and answer session. Those interested in participating on the call may dial 877-591-4953 (719-325-4796 for international callers) and provide access code 2986730 approximately 10 minutes prior to the start time. A live webcast of the call will be made available on the investor relations section of the Company’s website at http://ir.alliqua.com.

For those unable to participate, a replay of the call will be available for two weeks at 888-203-1112 (719-457-0820 for international callers); access code 2986730. The webcast will be archived on the investor relations section of Alliqua’s website.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Guidance, Hot Corp. News, Hot Guidance, Trading Halts

Related Entities

Raising Prices, Earnings

Add Your Comment